You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 24, 2025

Details for Patent: 11,117,867


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,117,867 protect, and when does it expire?

Patent 11,117,867 protects ORLADEYO and is included in one NDA.

This patent has twenty-one patent family members in twenty countries.

Summary for Patent: 11,117,867
Title:Crystalline salts of a plasma kallikrein inhibitor
Abstract: Disclosed are crystalline salts of Compound I, methods of preparing them, and related pharmaceutical preparations thereof. Also disclosed are methods of treatment using the crystalline salts of the invention. ##STR00001##
Inventor(s): El-Kattan; Yahya (Vestavia Hills, AL), Babu; Yarlagadda S. (Birmingham, AL)
Assignee: BioCryst Pharmaceuticals, Inc. (Durham, NC)
Application Number:16/784,016
Patent Claim Types:
see list of patent claims
Use; Composition; Compound; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis

Introduction

Patents are a crucial component of intellectual property law, providing inventors and innovators with exclusive rights to their inventions. To delve into the specifics of a U.S. patent, we will analyze the scope, claims, and the broader patent landscape, using U.S. Patent 11,117,867 as a case study.

What is a Patent?

A patent is a grant of a property right to the inventor, issued by the United States Patent and Trademark Office (USPTO), for a new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof[5].

Patent Scope and Claims

The scope of a patent is defined by its claims, which are the legally enforceable parts of the patent. The claims must be supported by a detailed specification that describes the invention and the manner and process of making and using it[5].

Independent Claim Length and Count

Research has shown that the scope of a patent can be measured using simple metrics such as independent claim length and independent claim count. These metrics have explanatory power for several correlates of patent scope, including patent maintenance payments, forward citations, and the breadth of patent classes. Narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

Patent Technology Areas

The USPTO classifies patent data filings into various technology areas, which can be aggregated to analyze trends in patenting focus over time. For instance, electrical and mechanical engineering patents made up about 60% of USPTO patents in 2018, with a significant increase in electrical engineering patents driven by information and communication technologies (ICT)[1].

Patent Ownership and Industry Trends

Patents are often granted to businesses, with a significant portion going to R&D-performing firms. In 2017, firms in the computer and electronics manufacturing industry received nearly 30,000 utility patents, reflecting their high levels of domestic R&D performance[1].

Patent Infringement and Litigation

The landscape of patent infringement litigation has seen significant changes. From 2007 to 2011, the number of defendants in patent infringement lawsuits increased by about 129%, with software-related patents accounting for a large portion of this increase. The Leahy-Smith America Invents Act (AIA) in 2011 also impacted litigation trends by limiting the number of defendants in a single lawsuit[4].

Patent Eligibility Under 35 U.S.C. § 101

Patent eligibility is a critical aspect of patent law, particularly under 35 U.S.C. § 101. The Alice test, a two-step framework, determines whether a patent claim is directed to patent-ineligible subject matter, such as an abstract idea. If the claim is deemed abstract, it must include elements that transform it into a patent-eligible application[2].

Alice Step One

The first step of the Alice test involves determining whether the claims are directed to patent-ineligible subject matter. This inquiry looks at the character of the claims as a whole to determine if they are focused on an abstract idea[2].

Alice Step Two

If the claims are found to be directed to an abstract idea, the second step examines whether the claim recites elements sufficient to transform it into a patent-eligible application. This step requires identifying an inventive step that goes beyond the abstract idea[2].

Case Study: U.S. Patent 11,117,867

While specific details of U.S. Patent 11,117,867 are not provided here, we can apply the general principles outlined above to understand its scope and claims.

Technology Area

To analyze this patent, one would first identify the technology area it falls under. This could be electrical engineering, mechanical engineering, or another field based on the WIPO classification system[1].

Claims Analysis

The claims of the patent would need to be scrutinized to determine their scope and whether they meet the criteria for patent eligibility under 35 U.S.C. § 101. This involves checking the independent claim length and count, as well as ensuring that the claims are supported by a detailed specification[3][5].

Ownership and Industry Context

Understanding who owns the patent and the industry context can provide insights into its significance. For example, if the patent is owned by a business in the computer and electronics manufacturing industry, it may reflect high R&D performance and significant innovation in that sector[1].

Key Takeaways

  • Patent Scope: Defined by the claims, which must be supported by a detailed specification.
  • Technology Areas: Patents are classified into various technology areas to analyze trends.
  • Ownership Trends: Businesses, especially those in high R&D industries, receive the majority of patents.
  • Patent Eligibility: The Alice test determines whether a patent claim is directed to patent-ineligible subject matter.
  • Litigation Trends: Changes in patent law and industry practices impact litigation, particularly in software-related patents.

FAQs

What is the purpose of a patent?

A patent is granted to provide the inventor with exclusive rights to their invention, encouraging innovation by protecting intellectual property.

How are patent claims measured for scope?

Patent scope can be measured using metrics such as independent claim length and independent claim count, which have explanatory power for various correlates of patent scope.

What is the Alice test in patent law?

The Alice test is a two-step framework used to determine whether a patent claim is directed to patent-ineligible subject matter, such as an abstract idea, and whether it includes elements that transform it into a patent-eligible application.

Which industries receive the most patents?

Firms in the computer and electronics manufacturing industry, along with those in computer systems design and related services, receive a significant number of patents due to their high levels of R&D performance.

How has the Leahy-Smith America Invents Act (AIA) impacted patent litigation?

The AIA has led to an increase in the number of patent infringement lawsuits by limiting the number of defendants in a single lawsuit, causing plaintiffs to break lawsuits into multiple cases.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 11,117,867

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Biocryst ORLADEYO berotralstat hydrochloride CAPSULE;ORAL 214094-001 Dec 3, 2020 RX Yes No 11,117,867 ⤷  Try for Free Y PROPHYLAXIS TO PREVENT ATTACKS OF HEREDITARY ANGIOEDEMA (HAE) IN ADULTS AND PEDIATRIC PATIENTS 12 YEARS OF AGE AND OLDER ⤷  Try for Free
Biocryst ORLADEYO berotralstat hydrochloride CAPSULE;ORAL 214094-002 Dec 3, 2020 RX Yes Yes 11,117,867 ⤷  Try for Free Y PROPHYLAXIS TO PREVENT ATTACKS OF HEREDITARY ANGIOEDEMA (HAE) IN ADULTS AND PEDIATRIC PATIENTS 12 YEARS OF AGE AND OLDER ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,117,867

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 116951 ⤷  Try for Free
Australia 2019374115 ⤷  Try for Free
Brazil 112021008249 ⤷  Try for Free
Canada 3117123 ⤷  Try for Free
Chile 2021001094 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.